A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland

American Journal of Epidemiology

Volumn 175, Issue 4, 2012, Pages 309-314

  Korhonen, Katariina ^a   Auvinen, Anssi ^b   Lyytinen, Heli ^c   Ylikorkala, Olavi ^c   Pukkala, Eero ^b,d  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d FINNISH CANCER REGISTRY   (Finland)

Author keywords

estrogens; medical record linkage; meningeal neoplasms; postmenopause; progestins; registries

Indexed keywords

DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; ESTRADIOL PLUS MEDROXYGESTERONE ACETATE; ESTRADIOL PLUS NORETHISTERONE ACETATE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

CANCER; COHORT ANALYSIS; HEALTH INSURANCE; HORMONE; IDENTIFICATION METHOD; RISK FACTOR; STANDARDIZATION; WOMENS HEALTH;

ADULT; AGED; ARTICLE; CANCER REGISTRY; COHORT ANALYSIS; DRUG INDUCED DISEASE; DRUG USE; FEMALE; FINLAND; FOLLOW UP; HORMONAL THERAPY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENINGIOMA; POSTMENOPAUSE; RISK ASSESSMENT; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FINLAND; HUMANS; INCIDENCE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; POISSON DISTRIBUTION; PROGESTINS; REGISTRIES; REGRESSION ANALYSIS; RISK;

FINLAND;

EID: 84856718850     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr335     Document Type: Article

References (29)

1. Gottfried ON, Gluf W, Quinones-Hinojosa A, et al. Spinal meningiomas: surgical management and outcome. Neurosurg Focus. 2003;14(6):e2.
2. Maiuri F, De Caro ML, de Divitiis O, et al. Spinal meningiomas: age-related features. Clin Neurol Neurosurg. 2011;113(1):34-38.
3. Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC; 2007.
4. Collins JA, Blake JM, Crosignani PG. Breast cancer risk with postmenopausal hormonal treatment. Hum Reprod Update. 2005;11(6):545-560. (Pubitemid 41631306)
5. Rao G, Giordano SH, Liu J, et al. The association of breast cancer and meningioma in men and women. Neurosurgery. 2009;65(3):483-489.
6. Custer BS, Koepsell TD, Mueller BA. The association between breast carcinoma and meningioma in women. Cancer. 2002;94(6):1626-1635. (Pubitemid 34241097)
7. Korhonen K, Salminen T, Raitanen J, et al. Female predominance in meningiomas cannot be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol. 2006;80(1):1-7. (Pubitemid 44473255)
8. Pravdenkova S, Al-Mefty O, Sawyer J, et al. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg. 2006;105(2):163-173.
9. Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg. 1997;86(1):113-120. (Pubitemid 27009982)
10. Rayter Z. Steroid receptors in breast cancer. Br J Surg. 1991; 78(5):528-535.
11. Wittliff JL. Steroid-hormone receptors in breast cancer. Cancer. 1984;53(suppl 3):630-643.
12. Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res. 2007;9(1):R6. (doi:10.1186/bcr1639). (Pubitemid 350215155)
13. Roser F, NakamuraM, Bellinzona M, et al. Proliferation potential of spinal meningiomas. Eur Spine J. 2006;15(2):211-215.
14. Jhawar BS, Fuchs CS, Colditz GA, et al. Sex steroid hormone exposures and risk for meningioma. J Neurosurg. 2003;99(5): 848-853. (Pubitemid 37314920)
15. Benson VS, Pirie K, Green J, et al. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women study. Million Women Study Collaborators. Int J Cancer. 2010;127(7):1692-1698.
16. Michaud DS, Gallo V, Schlehofer B, et al. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2562-2569.
17. Wigertz A, Lönn S, Mathiesen T, et al. Risk of brain tumors associated with exposure to exogenous female sex hormones. Swedish Interphone Study Group. Am J Epidemiol. 2006; 164(7):629-636. (Pubitemid 44453491)
18. Custer B, Longstreth WT Jr, Phillips LE, et al. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer. 2006; 6(1):152. (doi:10.1186/1471-2407-6-152). (Pubitemid 44144652)
19. Hatch EE, Linet MS, Zhang J, et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer. 2005;114(5):797-805. (Pubitemid 40344441)
20. Korhonen K, Raitanen J, Isola J, et al. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland. Cancer Causes Control. 2010;21(12): 2149-2156.
21. Pakarinen M, Raitanen J, Kaaja R, et al. Secular trend in the menopausal age in Finland 1997-2007 and correlation with socioeconomic, reproductive and lifestyle factors. Maturitas. 2010;66(4):417-422.
22. Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol. 2009;113(1):65-73.
23. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol. 1994;33(4):365-369. (Pubitemid 24207996)
24. Larjavaara S, Haapasalo H, Sankila R, et al. Is the incidence of meningiomas underestimated? A regional survey. Br J Cancer. 2008;99(1):182-184. (Pubitemid 351920236)
25. Klaeboe L, Lonn S, Scheie D, et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer. 2005;117(6): 996-1001. (Pubitemid 41688576)
26. Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J Clin Oncol. 2008;26(2):279-282.
27. Luoto R, Keskimäki I, Reunanen A. Socioeconomic variations in hysterectomy: evidence from a linkage study of the Finnish hospital discharge register and population census. J Epidemiol Community Health. 1997;51(1):67-73. (Pubitemid 27095939)
28. Nisolle M, Gillerot S, Casanas-Roux F, et al. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy. Hum Reprod. 1999;14(11):2844-2850. (Pubitemid 29520705)
29. Blankenstein MA, Koehorst SG, van der Kallen CJ, et al. Oestrogen receptor independent expression of progestin receptors in human meningioma-a review. J Steroid Biochem Mol Biol. 1995;53(1-6):361-365.